Stay updated on NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.

Latest updates to the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated to reflect a new version, v2.15.2, and the previous version, v2.15.0, has been removed. Additionally, the date has been changed from April 16, 2025, to April 29, 2025.SummaryDifference0.6%
- Check16 days agoChange DetectedThe date on the webpage has been updated from April 9, 2025, to April 16, 2025.SummaryDifference0.3%
- Check23 days agoChange DetectedThe web page has been updated to reflect a new version, v2.15.0, and a new date of April 9, 2025, replacing the previous version v2.14.4 and the date of March 3, 2025.SummaryDifference2%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 3, 2025.SummaryDifference0.6%
- Check66 days agoChange DetectedThe date has been updated from February 3, 2025, to March 3, 2025.SummaryDifference0.3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.